The emerging role of the microbiome in Alzheimer's disease

Elsevier

Available online 13 October 2022

International Review of NeurobiologyAbstract

Alzheimer's disease (AD) is the most prevalent form of dementia and can be influenced by genetic and environmental factors. Recent studies suggest that the intestinal microbiota is altered in AD patients when compared to healthy individuals and may play a role in disease onset and progression. Aging is the greatest risk factor for AD, and age-related changes in the microbiota can affect processes that contribute to cognitive decline. The microbiota may affect AD by modulating peripheral and central immunity or by secreting factors that influence neurogenesis or neuronal cell death. Finally, probiotic and dietary interventions that target the microbiome may have therapeutic potential to prevent or treat AD.

Keywords

Alzheimer's disease

Microbiota

Immunity

Probiotics

Microglia

View full text

Copyright © 2022 Elsevier Inc. All rights reserved.

留言 (0)

沒有登入
gif